Kingworld Medicines Group Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 847.39 million compared to CNY 745.38 million a year ago. Net income was CNY 30.32 million compared to CNY 11.72 million a year ago.

Basic earnings per share from continuing operations was CNY 0.05 compared to CNY 0.0191 a year ago. Diluted earnings per share from continuing operations was CNY 0.05 compared to CNY 0.0191 a year ago.